CorVel Corp. (NASDAQ:CRVL – Get Free Report) Director R Judd Jessup sold 3,247 shares of the business’s stock in a transaction on Friday, November 7th. The shares were sold at an average price of $76.20, for a total transaction of $247,421.40. Following the transaction, the director owned 111,798 shares of the company’s stock, valued at $8,519,007.60. This represents a 2.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
R Judd Jessup also recently made the following trade(s):
- On Tuesday, November 11th, R Judd Jessup sold 7,076 shares of CorVel stock. The stock was sold at an average price of $76.94, for a total value of $544,427.44.
- On Monday, November 10th, R Judd Jessup sold 210 shares of CorVel stock. The shares were sold at an average price of $76.27, for a total value of $16,016.70.
CorVel Price Performance
CRVL stock traded up $0.03 during trading on Monday, hitting $73.88. The stock had a trading volume of 221,406 shares, compared to its average volume of 146,591. CorVel Corp. has a twelve month low of $70.47 and a twelve month high of $128.61. The company’s 50-day moving average price is $75.20 and its two-hundred day moving average price is $90.15. The stock has a market capitalization of $3.79 billion, a P/E ratio of 38.08 and a beta of 0.98.
Hedge Funds Weigh In On CorVel
Several hedge funds and other institutional investors have recently made changes to their positions in CRVL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of CorVel by 0.7% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,961 shares of the business services provider’s stock worth $1,640,000 after purchasing an additional 115 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in shares of CorVel by 0.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,918 shares of the business services provider’s stock valued at $1,636,000 after acquiring an additional 139 shares in the last quarter. Arizona State Retirement System boosted its holdings in CorVel by 1.7% in the third quarter. Arizona State Retirement System now owns 9,113 shares of the business services provider’s stock worth $706,000 after purchasing an additional 155 shares during the period. Atria Investments Inc increased its stake in CorVel by 1.3% during the second quarter. Atria Investments Inc now owns 14,646 shares of the business services provider’s stock valued at $1,505,000 after purchasing an additional 186 shares during the last quarter. Finally, ProShare Advisors LLC boosted its position in CorVel by 3.0% during the 2nd quarter. ProShare Advisors LLC now owns 6,466 shares of the business services provider’s stock worth $665,000 after acquiring an additional 189 shares during the period. Institutional investors and hedge funds own 51.36% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on the stock. Wall Street Zen downgraded shares of CorVel from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Weiss Ratings reissued a “hold (c)” rating on shares of CorVel in a report on Tuesday, October 14th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold”.
Check Out Our Latest Stock Analysis on CRVL
About CorVel
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Featured Articles
- Five stocks we like better than CorVel
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- D-Wave: Time to Buy the Dip? Or is the Fall Just Starting?
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Hims, Block, and NRG Just Launched Huge Stock Buybacks
- How to Calculate Return on Investment (ROI)
- Retail Earnings Roundup: Walmart Scores, Target Slumps in Q3
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.
